Fusion proteins for use in the treatment of thyroid eye disease.
CL202601364A1Pending Publication Date: 2026-08-14H LUNDBECK AS +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202601364
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-27
- Filing Date
- 2026-04-28
- Publication Date
- 2026-08-14
Abstract
This disclosure relates to methods of treating thyroid eye disease (TED) by administering a fusion protein, such as a fusion protein as defined herein, to subjects in need. The disclosure provides treatment of TED pathophysiological parameters, including systemic and local pathophysiological parameters, by which the disease is effectively treated.
Need to check novelty before this filing date? Find Prior Art